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To the Editor:
Sterile alpha motif domain-and HD domain-containing protein 1 (SAMHD1) is a cellular dNTP triphosphohydrolase (dNTPase) that restricts HIV-1 replication in myeloid cells and resting CD4 + T cells by degrading dNTPs and limiting viral reverse transcription [1] [2] [3] [4] [5] . Purified recombinant SAMHD1 also has exonuclease activity when synthetic nucleic acids or HIV-1 gag and tat RNAs transcribed in vitro are used as substrates 6 . Ryoo et al. 7 recently suggested that SAMHD1 restricts HIV-1 infection through its ribonuclease (RNase) activity by cleaving the viral RNA genome. By using SAMHD1 mutants purported to specifically retain dNTPase (SAMHD1 Q548A ) or RNase (SAMHD1 D137N ) activities, Ryoo et al. 7, 8 proposed that the RNase activity of SAMHD1, but not its dNTPase activity, is essential for HIV-1 restriction in nondividing cells. They also suggested that SAMHD1 phosphorylation at T592 negatively regulated its RNase activity 7 .
To extend these findings 7 , we measured HIV-1 protein synthesis and virion production in the presence of SAMHD1 when the requirement for intracellular dNTP-dependent HIV-1 reverse transcription was bypassed. We co-transfected an HIV-1 proviral DNA plasmid (pNL4-3) with a plasmid expressing wild-type (WT) SAMHD1 or a phosphoablative, but dNTPase-active, mutant (SAMHD1 T592A ; refs. 9-11) into human embryonic kidney (HEK) 293T cells and assessed intracellular HIV-1 Gag protein synthesis and viral particle release in the supernatants. This transfection-based HIV-1 production is independent of reverse transcription requiring intracellular dNTPs as precursors of viral DNA synthesis, but is dependent on HIV-1 mRNA-mediated gene expression. Intracellular HIV-1 Gag protein levels, p24 capsid levels in released HIV-1 virions and infectivity were not reduced by the ectopic expression of WT SAMHD1 or SAMHD1 T592A mutant (Supplementary Fig. 1 ), which suggests that SAMHD1 cannot inhibit HIV-1 production after the reverse transcription step, regardless of its phosphorylation at T592. These findings are consistent with our previous results showing that the expression of WT SAMHD1 or of the SAMHD1 T592A mutant in dividing cells does not restrict HIV-1 infection 11, 12 . Our results suggest that SAMHD1 does not have broad nuclease activity, but do not rule out a specific nucleolytic interaction between SAMHD1 and incoming HIV-1 genomic RNA (gRNA).
Given the preponderance of previous data implicating the dNTPase activity of SAMHD1 as its primary antiviral mechanism, we reproduced the key experiments of Ryoo et al. 7 . Their conclusion that SAMHD1 restricts HIV-1 through RNase activity was based on the differential activity of the SAMHD1 mutants, SAMHD1 D137N and SAMHD1 Q548A (ref. 7) . We independently generated these two mutant constructs and confirmed the expected mutations by DNA sequencing to ensure that there were no other disabling mutations in the constructs. We then examined the HIV-1 restriction and intracellular dNTP regulation by these mutants and WT SAMHD1 by following the protocol of Ryoo et al. 7 . Our results show that both the SAMHD1 D137N and SAMHD1 Q548A mutants were expressed at similar levels to that of WT SAMHD1, and each efficiently restricted HIV-1 infection and decreased dATP, dGTP and dTTP levels in phorbol 12-myristate 13-acetate (PMA)-differentiated U937 cells (Fig. 1a-c) . SAMHD1 expression did not significantly decrease dCTP levels, as compared to vector control cells (Fig. 1c, right) , probably owing to the different biosynthesis pathway of dCTP. Notably, Ryoo et al. 7 showed only dCTP levels, but not dATP, dGTP or dTTP levels, in SAMHD1-expressing or control cells.
Previous studies have used a SAMHD1 D137A mutant to explore the effects of the dGTP binding site (D137) on the dNTPase activity, tetramer formation and HIV-1 restriction of SAMHD1 (refs. [13] [14] [15] . The SAMHD1 D137A mutant has no detectable dNTPase activity or HIV-1 restriction in vitro, owing to its inability to form a stable tetramer 14, 15 . It is possible that the SAMHD1 D137N mutant might be stabilized in cells to remain in a tetrameric form, thus maintaining its ability to reduce intracellular dNTP levels and restrict HIV-1 infection. It is also possible that an in vitro dNTPase assay using purified recombinant SAMHD1 proteins might not fully reflect the dNTPase activity of SAMHD1 in PMA-differentiated U937 cells. However, these possibilities remain to be examined to explain how the SAMHD1 D137N mutant restricts HIV-1 infection if its dNTPase activity is impaired. In contrast to the results of Ryoo et al. 7 , the SAMHD1 D137N and SAMHD1 Q548A mutants in our experiments do not have differing anti-HIV-1 activities, and neither lacks the ability to lower cellular dNTP levels.
Ryoo et al. 7 reported an approximately twofold decrease in HIV-1 gRNA levels in PMA-differentiated U937 cells expressing WT SAMHD1 or SAMHD1 D137N , but not the SAMHD1 Q548A mutant, as compared to the control cells at 3 h and 6 h postinfection (h.p.i.), which suggests SAMHD1-mediated HIV-1 gRNA degradation 7 . By contrast, we detected comparable levels of HIV-1 gRNA in PMAdifferentiated U937 cells expressing SAMHD1 (WT, SAMHD1 D137N and SAMHD1 Q548A mutants) and the vector control cells at 1, 3 and 6 h.p.i., respectively (Fig. 1d) , showing that, in our study, SAMHD1 cannot degrade HIV-1 gRNA during early infection. To further support our findings, we measured the levels of HIV-1 late reverse transcription products in infected cells at 12 and 24 h.p.i, which represent viral cDNA synthesis dependent on the intracellular dNTP pool. We found that the expression of WT SAMHD1, SAMHD1 D137N and SAMHD1 Q548A mutants significantly reduced HIV-1 late reverse transcription products as compared to the vector control cells (Fig. 1e) , correlating well with a reduced intracellular dNTP pool (Fig. 1c) . Thus, in our study, these two mutants of SAMHD1 cannot distinguish its dNTPase and RNase functions, and dNTP depletion accounts for SAMHD1-mediated HIV-1 restriction.
Seamon et al. 16 reported that trace exonuclease activities of recombi-
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on ssDNA and ssRNA resulted in products with distinct cleavage patterns, similar to previous observations 6, 7, 16 . However, the inconsistency of the RNase activity of SAMHD1 between different protein preparations suggests that the RNase activity is likely to be associated with contaminants, consistent with the results by Seamon et al. 16 .
The ability of SAMHD1 to restrict HIV-1 replication is thought to be through its dNTPase activity because the addition of exogenous deoxynucleosides rescues HIV-1 infectivity in SAMHD1-expressing cells 5, 17 and the anti-HIV activity of SAMHD1 is reversible 17 . These results suggest that dNTP depletion is the primary mechanism of nant SAMHD1 arise from contaminants during purification. To clarify whether recombinant SAMHD1 has a nuclease activity, we tested its ability to degrade single-stranded (ss) DNA and ssRNA substrates using stringently purified full-length recombinant SAMHD1. Purified SAMHD1 (Fig. 1f) exhibited a weak in vitro nuclease activity on both synthesized random ssDNA and ssRNA in some protein preparations (Fig. 1g, sample 1 ), whereas only a background level of nuclease activity was observed for other independent protein preparations under identical conditions (Fig. 1g, sample 2) . In all preparations, SAMHD1 had robust dNTPase activity, as expected (Fig. 1h) . The observed activity 
SAMHD1-mediated HIV-1 restriction, and argues against a nucleolytic mechanism. Our data and two recent studies 18, 19 do not support the conclusion that the RNase activity of SAMHD1 is involved in its anti-HIV-1 activity 7 , but are in agreement with its dNTPase activity as mediating HIV-1 restriction.
The discrepancy between our results and those of Ryoo et al. 7 might be due to different approaches, although we repeated HIV-1 infection and RT-qPCR experiments using the same methods (Fig. 1d) 7 . One difference was our use of the HIV-1-derived pLenti-puro vector to stably express high levels of SAMHD1 in PMA-differentiated U937 cells in HIV-1 restriction assays 11 , whereas Ryoo et al. used a murine stem cell virus-based pMSCV-puro vector 7 . We could not express high levels of SAMHD1 proteins in U937 cells using the pMSCV-puro vector (Supplementary Fig. 2 ). This might be due to lower expression driven by the long terminal repeat promoter of the pMSCV-puro vector, as compared to the cytomegalovirus promoter driving higher SAMHD1 expression from the pLenti vector. Previous studies showed that the efficiency of SAMHD1-mediated HIV-1 restriction in PMAdifferentiated U937 cells is dependent on the levels of SAMHD1 expression 14, 20 . Notably, the SAMHD1 expression levels in U937 cells were lower than the endogenous SAMHD1 levels in primary monocytederived macrophages from a healthy donor (Supplementary Fig. 3 ), which suggests that SAMHD1 expressed from the pLenti vector in U937 cells is not excessive. Different HIV-1 reporter vectors or other reagents used in these studies might also contribute to the discrepancy of the results. Overall, our data suggest that intracellular dNTP reduction by SAMHD1 is the primary mechanism of HIV-1 restriction in nondividing cells.
METHODS
Methods and any associated references are available in the online version of the paper.
Ryoo et al. reply:
Antonucci et al. 1 refute our recent findings that the RNase activity of SAM domain-and HD domain-containing protein 1 (SAMHD1) is involved in its HIV-1 restriction function because they did not show reproducible SAMHD1 RNase activity in vitro and were not able to reproduce the behavior of the two separated, functional SAMHD1 mutants D137N and Q548A. Our recent studies could explain why Antonucci et al. 1 , as well as previous studies [2] [3] [4] [5] , have arrived at contrasting conclusions about the RNase function of SAMHD1. These groups performed nuclease assays under the experimental conditions in which SAMHD1 is assumed to be a hydrolytic RNase that degrades RNA by an attack of water on the phosphodiester bond. We recently reported 6 that SAMHD1 requires inorganic phosphate to degrade RNA substrates. As a result, RNA degradation by SAMHD1 liberates nucleoside diphosphates rather than nucleoside monophosphates made by hydrolytic RNases 6 . These findings suggest that SAMHD1 is a phosphorolytic RNase rather than a hydrolytic RNase, as previously hypothesized.
Antonucci et al. 1 show that the expression of wild-type SAMHD1 or T592A mutant in human embryonic kidney 293T (HEK293T) cells does not restrict HIV-1 gene expression and its production, therefore leading to the conclusion that SAMHD1 does not target and degrade HIV-1 mRNA. These authors transfected HEK293T cells (dividing cells with high dNTP levels) with a DNA-based HIV-1 vector for analysis, whereas we infected differentiated U937 cells (nondividing myeloid cells with low dNTP levels) with HIV-1. Notably, SAMHD1 was identified as an HIV-1 restriction factor working in nondividing cells, including dendritic cells, myeloid cells and resting CD4 + T cells [7] [8] [9] . Thus, several reasons could account for their seemingly conflicting observations. First, as Antonucci et al. 1 pointed out, the accessibility of HIV-1 mRNA to SAMHD1 might be substantially different from that of incoming HIV-1 genomic (g) RNA. Second, a high dNTP concentration in dividing cells could affect the RNase activity of SAMHD1 through dGTP-induced oligomerization. This hypothesis is consistent with the report that the dGTP-bound tetramer of SAMHD1 has lower ssRNA-binding affinity than the monomeric SAMHD1 (ref. 2). Third, HIV-1 mRNA might be prevented from binding to the active site by competitive inhibition of dNTPs. In support of this idea, dGTP, as both a substrate and a co-factor of the npg CO R R E S P O N D E N C E and incomplete washing would offset the difference in viral RNA kinetics owing to a continuous entry of viruses. We have previously observed that SAMHD1 affects the stability of retroviral gRNA in SAMHD1-overexpressed or silenced cells 10, 14 . Prior to measuring HIV-1 gRNA level at 1, 3 and 6 h.p.i., target cells were infected with HIV-1 for 1 h, and unbound virus particles were stringently washed out. Furthermore, we used RNase H-defective HIV-1 (HIV-1 D443N ) to exclude the effect of the viral reverse transcriptase RNase H activity on the HIV-1 gRNA level. Under these experimental conditions, we were consistently able to detect statistically significant differences in the relative levels of HIV-1 gRNA between samples. Our new finding 6 that SAMHD1 is a phosphorolytic RNase indicates that we have to recalibrate the current 'dNTPase-centric' paradigm about the anti-HIV mechanisms of SAMHD1. We are looking forward to a productive scientific exchange upon the publication of advanced studies. SAMHD1 dNTPase function, inhibits the RNase activity of SAMHD1 in a dose-dependent manner 10 .
AUTHOR CONTRIBUTIONS
Antonucci et al. 1 observed that expression of the D137N mutant reduces intracellular dNTP levels, as compared to that of mock control, and inhibits HIV-1 reverse transcription, concluding that "dNTP depletion accounts for SAMHD1-mediated HIV-1 restriction. " However, the observation described in Antonucci et al. 1 contradicts those in other published reports. Several structural and biochemical studies have shown that D137 residue is located in the allosteric site and is crucial for dGTP-stimulated dNTPase activity 4, [11] [12] [13] . We have also demonstrated that the allosteric mutant D137N abolishes dNTPase activity and does not affect cellular dNTP levels 10 . In our original manuscript 10 , we showed the effect of the D137N mutant only on the concentration of intracellular dCTP. We observed that the cellular levels of neither dCTP nor of dATP, dGTP or dTTP were reduced in U937 cells expressing the D137N mutant in the same set of experiments (Fig. 1) , which further strengthens the idea that the D137N mutant has no dNTPase activity.
In contrast to the differences in the HIV-1 RNA levels that we observed in U937 cells expressing SAMHD1 variants 10 , Antonucci et al. 1 observed comparable levels of HIV-1 gRNA in phorbol 12-myristate 13-acetate (PMA)-differentiated U937 cells expressing SAMHD1 wild type (WT), D137N and Q548A mutants. The discrepant results described by Antonucci et al. 1 might be due to differences in the sensitivity of the experimental systems. In our experience, an apparent insensitivity of the assay systems might primarily point to issues with infection time and/or washing stringencies. Longer incubation times Figure 1 The allosteric mutant D137N abolishes dNTPase activity. Intracellular dNTP levels were measured in U937 cells stably expressing SAMHD1 variants, as described 10 . WT denotes wild-type SAMHD1, and D207N represents a catalytic SAMHD1 mutant. The data are presented as means ± s.d. of triplicate independent experiments. *P < 0.05, as compared to the mock-transfected control, using the two-tailed Student's t-test.
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